SCHEMBL7308049

SCHEMBL7308049

COc1ccc(O)c(NC(=O)C(F)(F)F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
P2RX1 P51575 1/20 0.49
TMPRSS4 Q9NRS4 1/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
F10 P00742 1/20 0.45
MTNR1A P48039 2/20 0.45
MTNR1B P49286 2/20 0.45
NQO2 P16083 1/20 0.45
HSP90AA1 P07900 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HDAC1 Q13547 1/20 0.44
GAA P10253 2/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27430704 0.88 TSHR (0.55) TSHRNPSR1P2RX1TMPRSS4CYP1A2
SCHEMBL14409902 0.84 GAA (0.51) TSHRNPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL2130017 0.83 NPSR1 (0.50) TSHRNPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL29977195 0.82 ALDH1A1 (0.51) TSHRNPSR1P2RX1TMPRSS4CYP1A2
SCHEMBL29785065 0.81 TSHR (0.74) TSHRNPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL29679686 0.81 NPSR1 (0.55) TSHRNPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL5788197 0.81 NPSR1 (0.55) TSHRNPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL2552734 0.81 TSHR (0.74) TSHRNPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL7256606 0.80 KMT2A (0.50) NPSR1MEN1KMT2AL3MBTL1F10
SCHEMBL2856689 0.80 LMNA (0.55) TSHRMEN1KMT2AL3MBTL1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0666260-B1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1999-08-04 EP disclosed
US-5550125-A BRAIN DISORDERS SYNTHELABO (FR) 1996-08-27 US disclosed
EP-0666260-A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1995-08-09 EP disclosed